Top Six Valuation Mistakes

Over 20 years as a financial analyst—and later, becoming Head of Research—has given me a lot of experience in forecasting and valuation. I started to build highly complex and detailed financial models early on as an analyst, but later realized that increased complexity rarely translates into increased accuracy. During these two decades, I developed a framework to value any company in the world and to help analysts avoid common mistakes in forecasting and valuation. Forecasting and valuation don’t work the way they are presented in the textbooks we study at university. The models are rarely accurate in their outcomes, either due to them relying on flawed assumptions or because certain parameters are impossible to correctly estimate. I wrote my Ph.D. dissertation on analyst earning forecast accuracy, so I should know! Unfortunately, analysts are not very accurate. I’ll tell you more about that in my upcoming free webinar for ValueWalk Readers: Top Six Valuation Mistakes.

Analysts are usually quite smart people, so why aren’t even smart people getting it right? One reason is that even quite experienced analysts make mistakes in their forecasting and valuation—many of which I’ve taught my teams and students techniques for how to avoid. Another reason is that models in textbooks usually work perfectly, but in reality, it’s impossible to estimate the parameters needed.

You’ve probably heard about the capital asset pricing model (CAPM). It states that the expected return of an asset is a function of the risk-free rate and the asset’s sensitivity (beta) to the expected market premium—or put simply: E(r) = Rf + B(E(Rm) – Rf). Let’s just say that CAPM is a valid model, what beta (B) should you use? The past three months? Six months? One year? Or maybe three years, five years or ten? What data frequency should you use when you estimate beta? Daily, weekly or monthly? These decisions can have a massive impact on the beta estimate you end up with. In valuation, the CAPM is often used to come up with the cost of equity. Hence, the beta will impact your discount rate and therefore the value.

Q2 Hedge Funds Portable Database Now LIVE!!! Letters, Conferences, Slides And More [UPDATED 7/13 14:48 EST]

Q2 Hedge Funds Resource PageSimply click the menu below to perform sorting functions. This page was just created on 7/1/2020 we will be updating it on a very frequent basis over the next three months (usually at LEAST daily), please come back or bookmark the page. As always we REALLY really appreciate legal letters and tips on hedge funds Read More

ValueWalk readers can sign up for free but hurry the audience is capped, so if you want a spot in the top six valuation mistakes just enter your name and email below or at this URL.

The date: 2017-11-21, Time: 16:00 Asia/Bangkok

I completed a study of 10,000 stocks over 20 years, to come up with my rules for how to estimate beta. Learn how to deal with the common mistakes with regards to beta as well as five other common mistakes that happen often in forecasting and valuation. I discuss all of these, and more, in my webinar: Top Six Valuation Mistakes. Forget your textbook, in this webinar, you’ll gain a truly practical perspective on valuation.


Andrew Stotz, PhD, CFA
CEO A. Stotz Investment Research

NOTE this is not a sponsored post we think this would be a value add to readers so wanted to highlight it – we only get comission if you sign up for a different course with Dr. Stotz (who is a regular contributor to ValueWalk and shrewd analyst IOHO) but this webinar is free and we make exactly zero dollars from it.

More info below

WEBINAR: Top six Valuation Mistakes with Andrew Stotz, PhD, CFA

“Learn the top six valuation mistakes and how to avoid them”

In this FREE Webinar:

·         Learn how Dr. Stotz’s method of valuation differs from others

·         Forget your textbook, let’s get a practical perspective on valuation

·         Learn the top 6 valuation mistakes and how to avoid them

·         Understand how you too can become a valuation master and get the edge in your career

Andrew Stotz, PhD, CFA is an award-winning stock market analyst who had 20 years on the clock at investment banks before starting A. Stotz Investment Research, a stock selection and fund advisory firm in Asia.

NOTE: We only have 100 spots for the ValueWalk webinar system available and space is expected to fill up fast so register now to avoid missing out. This webinar is packed with high-quality content!

Previous articleGlobal Liquidity Growth – The Risk Roadmap
Next articleThe Most Valuable Fintech Companies, In One Chart
Dr. Andrew Stotz, CFA is the CEO of A. Stotz Investment Research, a company providing institutional investors with ready-to- invest portfolios in Asia that aim to beat the benchmark through superior stock selection. The company also provides buy- and sell-side clients with financial models to value any company in the world and World Class Benchmarking to determine what companies are financially world class. Previously, as Head of Research at CLSA, Andrew was voted No. 1 Analyst in Thailand in the Asiamoney Brokers Polls for 2008 and 2009. He was also voted No. 1 Analyst in Thailand in the 2009 Institutional Investor magazine All-Asia Research Team Report. Andrew earned his PhD in finance at the University of Science and Technology of China in Anhui province, with a focus on answering questions raised by fund managers and analysts during his career about picking stocks and managing portfolios. In addition, Andrew has been a lecturer in finance for 22 years at various universities in Thailand. Since 2013, he has been the president of the CFA Society of Thailand. He is also the author of How to Start Building Your Wealth Investing in the Stock Market.